- Home
- PVBC vs BDTX Comparison
PVBC vs BDTX Comparison
Compare PVBC & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVBC
- BDTX
- Stock Information
- Founded
- PVBC 1913
- BDTX 2014
- Country
- PVBC United States
- BDTX United States
- Employees
- PVBC N/A
- BDTX N/A
- Industry
- PVBC Major Banks
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PVBC Finance
- BDTX Health Care
- Exchange
- PVBC Nasdaq
- BDTX Nasdaq
- Market Cap
- PVBC 223.5M
- BDTX 181.4M
- IPO Year
- PVBC 2015
- BDTX 2020
- Fundamental
- Price
- PVBC $12.92
- BDTX $3.35
- Analyst Decision
- PVBC Hold
- BDTX Strong Buy
- Analyst Count
- PVBC 1
- BDTX 6
- Target Price
- PVBC $12.50
- BDTX $12.50
- AVG Volume (30 Days)
- PVBC 28.7K
- BDTX 822.6K
- Earning Date
- PVBC 10-23-2025
- BDTX 11-04-2025
- Dividend Yield
- PVBC N/A
- BDTX N/A
- EPS Growth
- PVBC 47.58
- BDTX N/A
- EPS
- PVBC 0.62
- BDTX 0.25
- Revenue
- PVBC $59,149,000.00
- BDTX $70,000,000.00
- Revenue This Year
- PVBC $9.73
- BDTX N/A
- Revenue Next Year
- PVBC $4.87
- BDTX N/A
- P/E Ratio
- PVBC $20.79
- BDTX $13.20
- Revenue Growth
- PVBC 0.70
- BDTX N/A
- 52 Week Low
- PVBC $10.09
- BDTX $1.20
- 52 Week High
- PVBC $13.02
- BDTX $5.69
- Technical
- Relative Strength Index (RSI)
- PVBC 59.79
- BDTX 65.14
- Support Level
- PVBC $12.65
- BDTX $3.15
- Resistance Level
- PVBC $12.81
- BDTX $3.43
- Average True Range (ATR)
- PVBC 0.14
- BDTX 0.18
- MACD
- PVBC -0.02
- BDTX 0.02
- Stochastic Oscillator
- PVBC 75.00
- BDTX 89.19
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.